• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    Actinium Pharmaceuticals, Inc. (ATNM)

    -NYSE MKT
    2.56 Down 0.05(1.92%) 4:02PM EDT
    |After Hours : 2.50 Down 0.06 (2.34%) 4:27PM EDT
    Add to Portfolio
    Prev Close:2.61
    Open:2.58
    Bid:2.54 x 1400
    Ask:2.56 x 1600
    1y Target Est:16.00
    Beta:-1.44
    Next Earnings Date:N/A
    Day's Range:2.50 - 2.60
    52wk Range:2.31 - 8.12
    Volume:534,484
    Avg Vol (3m):1,093,640
    Market Cap:98.50M
    P/E (ttm):N/A
    EPS (ttm):-0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ATNM

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.69
    Quarterly EPS Est (Jun-15) :-0.19
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs for the treatment of cancer. The company develops therapies for life threatening diseases using its alpha particle immunotherapy platform and other related and similar tec... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback